- Nachrichtendetail
-
19.04.2024 13:14:22 - dpa-AFX: *MERCK: HEALTH CANADA APPROVES KEYTRUDA PLUS CHEMOTHERAPY FOR FIRST-LINE TREATMENT OF GASTRIC CANCERS IN ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 129,490 | 24.05.24 03:14:19 | -1,600 | -1,22% | 129,440 | 129,800 | 131,450 | 129,490 |
